Jushi Holdings (JUSHF) Amortization of Deferred Charges (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Amortization of Deferred Charges came in at $2.6 million in Q1 2026, up 19.24% year-on-year from $2.2 million in Q1 2025, and down 0.58% on a QoQ basis from $2.6 million in Q4 2025.
Jushi Holdings (JUSHF) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Amortization of Deferred Charges data on file, last reported at $2.6 million in Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges rose 19.24% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $10.2 million, a 32.57% increase from a year earlier, with the FY2025 full-year figure at $9.8 million, up 39.4% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $2.6 million, down from $2.6 million in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for JUSHF reached as high as $5.9 million in Q2 2022 and fell as low as $1.2 million in Q2 2023.
- Historically, Amortization of Deferred Charges has averaged $2.7 million across 5 years, with a median of $2.2 million in 2025.
- Across the five-year window, Amortization of Deferred Charges tumbled 79.8% in 2023 and soared 52.96% in 2024, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $3.8 million in 2022, then slumped by 50.63% to $1.9 million in 2023, then advanced by 4.59% to $2.0 million in 2024, then jumped by 31.48% to $2.6 million in 2025, then dropped by 0.58% to $2.6 million in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $2.6 million in Q1 2026, $2.6 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Jushi Holdings | 80.52 Mn | 40.82 Mn | 29.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.59 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Jun 30, 2025 | 2.46 Mn |
| Jun 30, 2025 | 2.46 Mn |
| Mar 31, 2025 | 2.17 Mn |
| Mar 31, 2025 | 2.17 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.81 Mn |
| Jun 30, 2024 | 1.81 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Dec 31, 2023 | 1.90 Mn |